Fig. 5From: A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer modelTumor growth curves and lung metastases in mice rechallenged with 344SQR cells. A Left, tumor growth curves for each of the surviving mice from the NBTXR3 + HDXRT + LDXRT + ICIs treatment group and the four control mice after rechallenge with 344SQR cells in the right flank. Right, images of excised tumors from the control group. B Numbers (left) and images (right) of lung metastases at 36 days after tumor rechallenge. Data are expressed as means ± standard error of the mean (SEM). P < 0.05 was considered statistically significant. *P < 0.05. HDXRT high-dose radiotherapy; LDXRT low-dose radiotherapy; ICIs immune checkpoint inhibitorsBack to article page